MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$72,869K
EPS
-$0.27
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-09-30
2025-06-30
2025-03-31
Impairment of operating lease right-of-use assets and related property and equipment
-0 0 -
Loss on disposal of property and equipment
-0 0 -3
Total revenue, net
26,218 21,194 20,923 8,982
Cost of sales
24,568 28,643 24,445 17,951
Research and development expenses, net
21,210 27,892 27,430 26,734
Selling, general and administrative expenses
39,953 36,280 30,265 29,534
Loss from operations
-59,513 -71,621 -61,217 -65,240
Other income, net
100 84 135 129
Foreign exchange (losses) gains, net
-2,667 -911 1,499 1,181
Interest income
2,469 4,382 5,234 6,137
Interest expense, net
11,124 10,520 -6,829 10,143
Total other (expenses) income, net
-11,222 -6,965 13,697 -2,696
Net loss before income tax
-70,735 -78,586 -47,520 -67,936
Income tax expense
863 532 397 2,225
Net loss
-71,598 -79,118 -47,917 -70,161
Foreign currency exchange translation adjustment
-1,130 -5,868 18,990 10,668
Unrealized holding (losses) gains on available-for-sale debt securities, net of tax of 0 and 0, respectively
-141 86 -22 400
Total other comprehensive (loss) income, net of tax
-1,271 -5,782 18,968 11,068
Total comprehensive loss
-72,869 -84,900 -28,949 -59,093
Basic EPS
-0.27 -0.3 -0.18 -0.26
Diluted EPS
-0.27 -0.3 -0.18 -0.26
Basic Average Shares
266,143,425 266,141,431 266,141,411 266,126,548
Diluted Average Shares
266,143,425 266,141,431 266,141,411 266,126,548
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$72,869K (-23.31%↓ Y/Y)Net loss-$71,598K (-2.05%↓ Y/Y)Total othercomprehensive (loss) income,...-$1,271K (-111.48%↓ Y/Y)Net loss beforeincome tax-$70,735K (-4.12%↓ Y/Y)Income tax expense$863K (-61.21%↓ Y/Y)Foreign currencyexchange translation...-$1,130K (-110.59%↓ Y/Y)Unrealized holding(losses) gains on...-$141K (-135.25%↓ Y/Y)Loss from operations-$59,513K (8.78%↑ Y/Y)Total other(expenses) income, net-$11,222K (-316.25%↓ Y/Y)Total revenue, net$26,218K (191.89%↑ Y/Y)Interest income$2,469K (-59.77%↓ Y/Y)Other income, net$100K (-22.48%↓ Y/Y)Selling, general andadministrative expenses$39,953K (35.28%↑ Y/Y)Cost of sales$24,568K (36.86%↑ Y/Y)Interest expense, net$11,124K (9.67%↑ Y/Y)Foreign exchange(losses) gains, net-$2,667K (-325.83%↓ Y/Y)Research and developmentexpenses, net$21,210K (-20.66%↓ Y/Y)

Autolus Therapeutics plc (AUTL)

Autolus Therapeutics plc (AUTL)